Frontiers in Physiology (Apr 2018)

Serum-Derived Extracellular Vesicles Protect Against Acute Myocardial Infarction by Regulating miR-21/PDCD4 Signaling Pathway

  • Huanyu Gu,
  • Zhuyuan Liu,
  • Yongqin Li,
  • Yuan Xie,
  • Jianhua Yao,
  • Yujiao Zhu,
  • Jiahong Xu,
  • Qiying Dai,
  • Chongjun Zhong,
  • Hao Zhu,
  • Shengguang Ding,
  • Lei Zhou

DOI
https://doi.org/10.3389/fphys.2018.00348
Journal volume & issue
Vol. 9

Abstract

Read online

Acute myocardial infarction (AMI) represents a leading cause of morbidity and mortality worldwide. Extracellular vesicles (EVs) are being recognized as a promising therapeutic approach in protecting against MI. Serum is a rich source of EVs, which transports various microRNAs (miRNAs, miRs). EVs from serum have been shown beneficial for protecting against ischemia-reperfusion injury; however, their roles in AMI are unclear. In addition, whether a miRNA might be responsible for the effects of serum EVs on protecting against AMI is undetermined. Here, we demonstrated that serum EVs significantly reduced cardiomyocytes apoptosis in both cellular and mouse models of AMI, and dramatically attenuated the infarct size in mouse hearts after AMI. Inhibition of miR-21 was shown to reduce the protective effects of serum EVs in inhibiting cardiomyocytes apoptosis. miR-21 was decreased in mouse hearts after AMI, while serum EVs increased that. In addition, the programmed cell death 4 (PDCD4) expression was identified as a target gene of miR-21. Therefore, our study showed the protective effects of serum EVs on AMI, and provided a novel strategy for AMI therapy.

Keywords